alniditan has been researched along with Abdominal Migraine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R | 1 |
| Dahlöf, CG; Diener, HC; Goldstein, J; Olesen, J; Schellens, R; Senard, JM; Simard, D; Steiner, TJ | 1 |
| Audinot-Bouchez, V; Chaput, C; Conte, C; Lavielle, G; Lochon, S; Millan, MJ; Newman-Tancredi, A; Verrièle, L | 1 |
| De Vries, P; Heiligers, JP; Saxena, PR; Villalón, CM; Willems, EW | 1 |
| de Beukelaar, F; Ferrari, MD; Roon, KI; Soons, PA; Uitendaal, MP | 1 |
| De Beukelaar, F; Diener, HC; Louis, P; Schellens, R | 1 |
| Dahlöf, C; de Beukelaar, F; Diener, HC; Ferrari, MD; Mathew, N; Olesen, J; Tfelt-Hansen, P | 1 |
3 trial(s) available for alniditan and Abdominal Migraine
| Article | Year |
|---|---|
Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group.
Topics: Adult; Benzopyrans; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Migraine Disorders; Propylamines; Pyrimidines; Serotonin Receptor Agonists; Vasoconstrictor Agents | 1996 |
Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Area Under Curve; Benzopyrans; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nasal Mucosa; Propylamines; Pyrimidines; Taste Disorders; Vasoconstrictor Agents | 1999 |
The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Analysis of Variance; Benzopyrans; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Placebos; Propylamines; Pyrimidines; Sumatriptan; Vasoconstrictor Agents | 2001 |
4 other study(ies) available for alniditan and Abdominal Migraine
| Article | Year |
|---|---|
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorders; Propylamines; Protein Binding; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents | 1996 |
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Cell Membrane; Cricetinae; Dihydroergotamine; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Lisuride; Methysergide; Migraine Disorders; Piperazines; Piperidines; Pizotyline; Propranolol; Propylamines; Protein Binding; Pyridines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 1997 |
The antimigraine agent alniditan selectively constricts porcine carotid arteriovenous anastomoses via 5-HT1B/1D receptors.
Topics: Analgesics; Animals; Arteriovenous Anastomosis; Benzopyrans; Carotid Arteries; Hemodynamics; Humans; Jugular Veins; Male; Migraine Disorders; Oxadiazoles; Oxygen; Piperazines; Propylamines; Pyrimidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swine; Vasoconstrictor Agents | 1998 |
Treatment of migraine attacks with intranasal alniditan: an open study.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Benzopyrans; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Migraine Disorders; Propylamines; Pyrimidines; Treatment Outcome; Vasoconstrictor Agents | 2001 |